Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases 글 내용 전체보기
Sapreme Technologies in a 6.8 M€ EU Alliance to Develop an Oligonucleotide Delivery Platform Based on Its Proprietary Endosomal Escape Enhancers 글 내용 전체보기
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report 글 내용 전체보기
Pfizer switches RA patients to lower dose of fast-growing Xeljanz as safety issues arise in postmarketing study 글 내용 전체보기
